ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

Former NCI Executive Lands Key Senate Staff Position

February 4, 1977

José Baselga Named Physician-in-Chief Of Memorial Sloan-Kettering Hospital

September 21, 2012

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

July 27, 2007

NSABP Executive Committee Is Seeking Applications From Surgeons to Lead Group

July 29, 1994

AACR Campaigns For Doubling Funding for Cancer Research In Three Years

April 25, 1997